Navigating the Deep Waters of Pharma Reform: How Digital Marketing Solutions Are Reshaping the Industry

In recent years, the trend toward digitalization in pharmaceutical marketing has intensified.

Driven by the dual forces of healthcare reform policies and the COVID-19 pandemic, digital marketing in China’s pharmaceutical industry has reached a new level. Both physicians’ acceptance of digital and compliant approaches and the urgency with which healthcare enterprises seek to adopt digital marketing have hit new peaks.

As a core product of digital marketing in the pharmaceutical industry, virtual representatives are seeing rapidly growing demand from pharmaceutical and medical device companies. Although there are various digital marketing methods and platforms, physicians remain the primary target audience, and physician engagement continues to serve as the fundamental basis of marketing strategies. Therefore,Digital marketing is inseparable from virtual representative platforms.

Recently, Udesk, a leading domestic artificial intelligence company and customer experience solutions provider, has launchedVirtual Representative Session Analysis Empowerment Platform.VCBeat conducted an exclusive interview with Udesk to gain insights into the genuine needs of pharmaceutical companies for digital marketing platforms in the pharmaceutical industry. The interview also aimed to dissect UDesk’s virtual representative platform, analyzing how artificial intelligence can bring truly efficient, compliant, and precise marketing methods to the industry.

For healthcare companies in the Chinese market, digital pharmaceutical marketing has long shifted from being a “better option” to a “necessary choice.”

From the broader policy landscape, the implementation of policies such as tiered diagnosis and treatment, consistency evaluation, the “4+7” volume-based procurement, and DRGs has hindered traditional offline visits. The commission-based sales model is gradually becoming a thing of the past, and pharmaceutical marketing is rapidly transforming toward digitalization.

Challenges Facing Pharmaceutical Sales Representatives

From the perspective of the trend in healthcare resource redistribution, medical resources are continuously shifting toward primary care. China has nearly one million primary care and health institutions; while numerous, they are geographically dispersed. Offline visits struggle to reach this vast primary care market, creating a need for efficient, cost-effective, and compliant penetration into the primary healthcare sector, which has further spurred demand for digital pharmaceutical marketing.

In the traditional pharmaceutical marketing system, offline representatives are the main body,In the era of compliant and efficient digital marketing, virtual representatives are naturally a key element.

Virtual representatives feature broad coverage, high efficiency, and low cost, aligning closely with pharmaceutical companies’ digital marketing needs. Wofeng Technology stated: “Virtual representatives are divided into three stages,First, it is a communication tool., communicate with physicians through digital means,Secondly, an intelligent platform, intelligently review and analyze large volumes of conversations and data, ultimately enabling effective interaction with field representatives, healthcare institutions, pharmacies, and other stakeholders.Proficient in community management.”

VCBeat has long focused on the field of digital pharmaceutical marketing and has identified two major issues in the niche market of virtual representatives,First, there is a scarcity of relevant products, which falls far short of meeting the robust demand from healthcare enterprises. Second, most platforms remain at the stage of communication tools, failing to achieve truly efficient and precise marketing; at best, they function merely as telemarketing platforms.

Udesk Technology told VCBeat, “Virtual representative platforms face high technical barriers, requiring expertise in IT, AI, and big data, as well as significant medical thresholds, with compliance requirements posing a major challenge.” The current awkward predicament of virtual representative platforms has enabled Udesk Technology, an artificial intelligence company with years of experience in the healthcare sector, to keenly identify new opportunities.

Wofeng Technology’s R&D team comprises over 300 members, leveraging core technologies such as cloud computing, big data, and AI to build a leading domesticIntegrated Customer Lifecycle Solution, forming a five-product matrix comprising the Udesk intelligent customer service system, the GaussMind intelligent product line, the WeFeng SCRM based on Enterprise WeChat, the ServiceGo integrated sales and service platform, and the CusBridge intelligent customer experience management platform. This approach applies comprehensive intelligent systems to all enterprise customer service scenarios, helping businesses achieve digital and intelligent transformation in customer relationship management.

Currently, Wofeng TechnologyServed over 50,000 clients, including more than 60 Fortune Global 500 companies and over 150 China Fortune 500 enterprises, and holds the record for the highest publicly disclosed financing amount in the industry.

Since its inception, healthcare has been one of Udesk’s key focus areas. In recent years, UDesk has observed that virtual representatives are emerging as a novel business model under a series of healthcare reform policies. “Leveraging our prior technological reserves, along with our AI implementation and community operation experience across multiple sectors, we rapidly customized and upgraded our existing products to build a virtual representative platform.”

It is well known that even the largest technology companies often struggle to adapt when entering the healthcare sector. Why has Wofeng Technology been able to press forward unimpeded in the healthcare field for many years? What underpins its recent launch of virtual representatives? To address these questions, VCBeat identified several core competencies of Wofeng Technology: medical expertise, AI capabilities, and regulatory compliance.

Medical insights are the primary prerequisite for the research and development of all medical products.Developers of virtual representative platforms are predominantly IT companies, with a significant shortfall in accumulated medical expertise. In contrast, Udesk has deep roots in the healthcare sector and boasts a professional medical team. It formulates strategies driven by customer needs and grounded in real-world business operations and market conditions, rather than creating a detached, high-tech product.

“For example, while serving a leading medical device company, we conducted a two-month on-site engagement to thoroughly investigate operational bottlenecks across all business segments and developed a tailored solution.”

AI capabilities are an indispensable and critical foundation for virtual representative platforms.Wofeng Technology’s self-developed “Yuanxin Engine” leverages ASR-NLP speech-semantic fusion to create an engine capable of understanding semantics through scenario reconstruction, speech-semantic integration, and adaptive learning. Furthermore, Wofeng Technology possesses a proprietary speech-semantic recognition model tailored for the pharmaceutical industry, achieving a medical terminology recognition rate of up to 97%.

Leveraging the “Yuanxin Engine,” Udesk empowers pharmaceutical companies to build digital knowledge base systems, integrate internal and external data, and achieve intelligent search and recommendation capabilities for comprehensive smart knowledge management. Additionally, it enables real-time knowledge recommendation support, conversation quality inspection and analysis, physician profiling, precise matching of related medications, and automated consultations and follow-ups via intelligent chatbots, thereby delivering intelligent services.

Furthermore, the pharmaceutical industry is subject to stringent compliance requirements, necessitating that sales activities and communication processes remain fully compliant.Udesk holds qualifications including Level 3 Classified Protection of Cybersecurity, Call Center Business License, and ISO 27001 Information Security Certification. It has achieved full-process digitalization and traceability to ensure compliant project operations. By intelligently identifying compliance risks, it can eliminate 100% of such risks, significantly reducing the time and costs for compliance teams through AI.

Udesk Virtual Agent Conversation Analytics Empowerment Platform

Data provided by Wofeng Technology shows that its virtual representative platform canReduce low-value communication, improve communication skills by 100%, cut staff training time by 80%, and enhance personnel performance insights by 200%.

In the future, the trend toward digital marketing in the pharmaceutical industry will accelerate further. Amid constrained promotional budgets and increasingly stringent compliance requirements, healthcare companies need to reach a larger number of physicians and extend their presence into the broader primary-care market. This will drive growing demand for efficient communication methods and community management, while physicians’ desire for professional medical knowledge will intensify, marking a return to the essence of academic promotion.

Therefore,It is no surprise that virtual representative platforms have rapidly gained popularity, as they represent a critical pathway for the long-term and sustainable development of pharmaceutical marketing.

Currently, Udesk has served over 100 healthcare and medical enterprises, including Xi’an Janssen, Merck & Co., Zai Lab, WuXi AppTec, and Yuwell Medical. Its virtual representative platform has collaborated with multiple leading pharmaceutical companies across various therapeutic areas. Amid the rising trend of digital marketing in the pharmaceutical industry, the virtual representative platform is a flagship product of Udesk. Moving forward, the company will continue to deepen collaborations with numerous healthcare clients, strengthening its capabilities in AI, medical expertise, and innovation to meet the diverse needs of customers for its virtual representative platform.

Product Value of Virtual Pharmaceutical Representatives

The performance of virtual representative platforms is closely tied to AI capabilities. It is foreseeable that Udesk, having established a competitive moat in both AI capabilities and specialized medical knowledge, will drive innovation in pharmaceutical marketing through its launched Pharmaceutical Virtual Representative Conversation Analysis Empowerment Platform.